Literature DB >> 11097857

Expression and binding analysis of GST-VacA fusions reveals that the C-terminal approximately 100-residue segment of exotoxin is crucial for binding in HeLa cells.

H J Wang1, W C Wang.   

Abstract

The Helicobacter pylori toxin VacA induces intracellular vacuolation and plays an essential role in H. pylori-related diseases. The mature exotoxin is divided into two domains, P37 and P58. A soluble form of VacA fused with GST was expressed in Escherichia coli. Although the soluble fusion lacked vacuolating activity after cleavage by thrombin, it had a binding affinity similar to that of the native VacA. Moreover, it blocked the vacuolating activity induced by the native toxin. Different C-terminal truncated fusions were generated (GST-P72, GST-P53, and GST-P37) and were also produced in a soluble form. A significantly reduced binding activity was seen for GST-P72 and nearly no specific association was detected for GST-P37. Our results suggested that the whole P58 fragment contributed to the cell binding activity in HeLa cells, particularly in the C-terminal approximately 100-residue region. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11097857     DOI: 10.1006/bbrc.2000.3820

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Plasma membrane cholesterol modulates cellular vacuolation induced by the Helicobacter pylori vacuolating cytotoxin.

Authors:  Hetal K Patel; David C Willhite; Rakhi M Patel; Dan Ye; Christopher L Williams; Eric M Torres; Kent B Marty; Robert A MacDonald; Steven R Blanke
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

2.  Fluorescence resonance energy transfer microscopy of the Helicobacter pylori vacuolating cytotoxin within mammalian cells.

Authors:  David C Willhite; Dan Ye; Steven R Blanke
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

3.  Expression of Helicobacter pylori vacuolating toxin in Escherichia coli.

Authors:  Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

4.  Reconstitution of Helicobacter pylori VacA toxin from purified components.

Authors:  Christian González-Rivera; Kelly A Gangwer; Mark S McClain; Ilyas M Eli; Melissa G Chambers; Melanie D Ohi; D Borden Lacy; Timothy L Cover
Journal:  Biochemistry       Date:  2010-07-13       Impact factor: 3.162

5.  Antigenic diversity among Helicobacter pylori vacuolating toxins.

Authors:  A D Vinion-Dubiel; M S McClain; P Cao; R L Mernaugh; T L Cover
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

6.  A Helicobacter pylori Vacuolating Cytotoxin A: Mouse DHFR Fusion Protein Triggers Dye Release from Liposomes.

Authors:  Aung Khine Linn; Nitchakan Samainukul; Somsri Sakdee; Chanan Angsuthanasombat; Gerd Katzenmeier
Journal:  Curr Microbiol       Date:  2017-10-14       Impact factor: 2.188

7.  Determinants of Raft Partitioning of the Helicobacter pylori Pore-Forming Toxin VacA.

Authors:  Krishnan Raghunathan; Nora J Foegeding; Anne M Campbell; Timothy L Cover; Melanie D Ohi; Anne K Kenworthy
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

8.  Analysis of a beta-helical region in the p55 domain of Helicobacter pylori vacuolating toxin.

Authors:  Susan E Ivie; Mark S McClain; Holly M Scott Algood; D Borden Lacy; Timothy L Cover
Journal:  BMC Microbiol       Date:  2010-02-23       Impact factor: 3.605

9.  Helicobacter pylori VacA subdomain required for intracellular toxin activity and assembly of functional oligomeric complexes.

Authors:  Susan E Ivie; Mark S McClain; Victor J Torres; Holly M Scott Algood; D Borden Lacy; Rong Yang; Steven R Blanke; Timothy L Cover
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

10.  Crystal structure of the Helicobacter pylori vacuolating toxin p55 domain.

Authors:  Kelly A Gangwer; Darren J Mushrush; Devin L Stauff; Ben Spiller; Mark S McClain; Timothy L Cover; D Borden Lacy
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.